Clinical Study to Evaluate the Tooth Whitening Efficacy of a New NextGen In-office Whitening System
← catalyst calendarSponsored by Colgate Palmolive (industry) · CL — their whole pipeline →.
Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Randomized · Double · Treatment
Enrollment
180actual
Sites
1
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-10-31 | actual | When the study began enrolling |
| Primary completion | 2025-12-21 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-12-21 | actual | The whole study's end, after follow-up |
| First posted | 2025-11-06 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-01-08 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Health Adult Subjects
Interventions
- Drug: Beaming White
- Combination product: Philips Zoom Professional Whitening Treatment
- Combination product: Opalescence Boost PF
- Drug: Fluoride Toothpaste
- Device: Soft Manual Toothbrush
- Device: CP LED
- Device: Gingival Barrier
Primary outcome
what the primary-completion date above is the date OFWhitening Improvements
measured Immediately after whitening and 1 week later.
Permalink · CL's whole pipeline · Catalyst calendar · Every registered study · What changed